Procept Biorobotics Corp (NASDAQ:PRCT) — Market Cap & Net Worth
Market Cap & Net Worth: Procept Biorobotics Corp (PRCT)
Procept Biorobotics Corp (NASDAQ:PRCT) has a market capitalization of $1.17 Billion ($1.17 Billion) as of June 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #8401 globally and #2374 in its home market, demonstrating a -27.35% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Procept Biorobotics Corp's stock price $20.91 by its total outstanding shares 55878589 (55.88 Million). Review how much debt does Procept Biorobotics Corp carry to assess the company's total debt and financial obligations.
Procept Biorobotics Corp Market Cap History: 2021 to 2026
Procept Biorobotics Corp's market capitalization history from 2021 to 2026. Data shows change from $1.40 Billion to $1.17 Billion (-13.61% CAGR).
Index Memberships
Procept Biorobotics Corp is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.42 Trillion | 0.05% | #231 of 976 |
|
NASDAQ Composite
IXIC
|
$40.74 Trillion | 0.00% | #888 of 3165 |
Weight: Procept Biorobotics Corp's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Procept Biorobotics Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Procept Biorobotics Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
20.04x
Procept Biorobotics Corp's market cap is 20.04 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $1.40 Billion | $34.47 Million | -$59.85 Million | 40.54x | N/A |
| 2022 | $2.32 Billion | $75.01 Million | -$87.15 Million | 30.94x | N/A |
| 2023 | $2.34 Billion | $136.19 Million | -$105.90 Million | 17.20x | N/A |
| 2024 | $4.50 Billion | $224.50 Million | -$91.41 Million | 20.04x | N/A |
Competitor Companies of PRCT by Market Capitalization
Companies near Procept Biorobotics Corp in the global market cap rankings as of June 18, 2026.
Key companies related to Procept Biorobotics Corp by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #149 globally with a market cap of $153.89 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #212 globally with a market cap of $115.24 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #236 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #252 globally with a market cap of $100.32 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #149 | Abbott Laboratories | NYSE:ABT | $153.89 Billion | $88.50 |
| #212 | Stryker Corporation | NYSE:SYK | $115.24 Billion | $301.14 |
| #236 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #252 | Medtronic PLC | NYSE:MDT | $100.32 Billion | $78.14 |
Procept Biorobotics Corp Historical Marketcap From 2021 to 2026
Between 2021 and today, Procept Biorobotics Corp's market cap moved from $1.40 Billion to $ 1.17 Billion, with a yearly change of -13.61%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.17 Billion | -33.53% |
| 2025 | $1.76 Billion | -60.93% |
| 2024 | $4.50 Billion | +92.13% |
| 2023 | $2.34 Billion | +0.89% |
| 2022 | $2.32 Billion | +66.09% |
| 2021 | $1.40 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 18th, 2026 the market cap of Procept Biorobotics Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.17 Billion USD |
| MoneyControl | $1.17 Billion USD |
| MarketWatch | $1.17 Billion USD |
| marketcap.company | $1.17 Billion USD |
| Reuters | $1.17 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Procept Biorobotics Corp
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. It also provides HYDROS Rob… Read more